Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes

Journal of Perinatology volume 29, pages S29–S37 (2009)Cite this article

Abstract

Deficiency or dysfunction of the pulmonary surfactant plays a critical role in the pathogenesis of respiratory diseases of the newborn. After a short review of the pulmonary surfactant, including its role in selected neonatal respiratory conditions, we describe a series of studies conducted by applying two recently developed methods to measure surfactant kinetics. In the first set of studies, namely ‘endogenous studies’, which used stable isotope-labeled intravenous surfactant precursors, we have shown the feasibility of measuring surfactant synthesis and kinetics in infants using several metabolic precursors, including plasma glucose, plasma fatty acids and body water. In the second set of studies, namely ‘exogenous studies’, which used a stable isotope-labeled phosphatidylcholine (PC) tracer given endotracheally, we estimated the surfactant disaturated phosphatidylcholine (DSPC) pool size and half-life. The major findings of our studies are presented here and can be summarized as follows: (a) the de novo synthesis and turnover rates of the surfactant (DSPC) in preterm infants with respiratory distress syndrome (RDS) are very low with either precursor; (b) in preterm infants with RDS, pool size is very small and half-life much longer than what has been reported in animal studies; (c) patients recovering from RDS who required higher continuous positive airway pressure pressure after extubation or reintubation have a lower level of intrapulmonary surfactant than those who did well after extubation; (d) term newborn infants with pneumonia have greatly accelerated surfactant catabolism; and (e) infants with uncomplicated congenital diaphragmatic hernia (CDH) and on conventional mechanical ventilation have normal surfactant synthesis, but those requiring extracorporeal membrane oxygenated (ECMO) do not. Information obtained from these studies in infants will help to better tailor exogenous surfactant treatment in neonatal lung diseases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Avery ME, Mead J . Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 1959; 97: 517–523.

    CAS  Google Scholar 

  2. Fujiwara T, Maeta H, Chida S, Morita T, Watabe Y, Abe T . Artificial surfactant therapy in ialine membrane disease. Lancet 1980; i: 55–59.

    Article  Google Scholar 

  3. Phelps DS . Surfactant regulation of host defense function in the lung: a question of balance. Pediatr Pathol Mol Med 2001; 20 (4): 269–292.

    Article  CAS  PubMed  Google Scholar 

  4. Hunt AN, Kelly FJ, Postle AD . Developmental variation in whole human lung phosphatidylcholine molecular species: a comparison with guinea pig and rat. Early Hum Dev 1991; 25 (3): 157–171.

    Article  CAS  PubMed  Google Scholar 

  5. Haagsman HP, Diemel RV . Surfactant-associated proteins: functions and structural variation. Comp Biochem Physiol A Mol Integr Physiol 2001; 129 (1): 91–108.

    Article  CAS  PubMed  Google Scholar 

  6. Korfhagen TR, Bruno MD, Ross GF, Huelsman KM, Ikegami M, Jobe AH et al. Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA 1996; 93 (18): 9594–9599.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Crouch EC . Collectins and pulmonary host defense. Am J Respir Cell Mol Biol 1998; 19 (2): 177–201.

    Article  CAS  PubMed  Google Scholar 

  8. Botas C, Poulain F, Akiyama J, Brown C, Allen L, Goerke J et al. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci USA 1998; 95 (20): 11869–11874.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Nogee LM, de Mello DE, Dehner LP, Colten HR . Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993; 328 (6): 406–410.

    Article  CAS  PubMed  Google Scholar 

  10. deMello DE, Heyman S, Phelps DS, Hamvas A, Nogee L, Cole S et al. Ultrastructure of lung in surfactant protein B deficiency. Am J Respir Cell Mol Biol 1994; 11 (2): 230–239.

    Article  CAS  PubMed  Google Scholar 

  11. Glasser SW, Burhans MS, Korfhagen TR, Na CL, Sly PD, Ross GF et al. Altered stability of pulmonary surfactant in SP-C-deficient mice. Proc Natl Acad Sci USA 2001; 98 (11): 6366–6371.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Rebello CM, Jobe AH, Eisele JW, Ikegami M . Alveolar and tissue surfactant pool sizes in humans. Am J Respir Crit Care Med 1996; 154: 625–628.

    Article  CAS  PubMed  Google Scholar 

  13. Jobe A, Ikegami M . Movement of fluid and particles between the airspaces and pulmonary interstitium protein permeability abnormalities in the preterm. In: Effros R, Chang H (eds). Fluid and Solute Transport in the Airspaces of the Lungs (Lung Biology in Health and Disease). Marcel Dekker Inc.: New York, 1994, pp 335–355.

    Google Scholar 

  14. Batenburg JJ . Surfactant phospholipids: synthesis and storage. Am J Physiol 1992; 262 (4 Part 1): L367–L385.

    CAS  PubMed  Google Scholar 

  15. Jacobs H, Jobe A, Ikegami M, Conaway D . The significance of reutilization of surfactant phosphatidylcholine. J Biol Chem 1983; 258: 4156–4165.

    Google Scholar 

  16. Wright JR, Dobbs LG . Regulation of pulmonary surfactant secretion and clearance. Annu Rev Physiol 1991; 53: 395–414.

    Article  CAS  PubMed  Google Scholar 

  17. Martini WZ, Chinkes DL, Barrow RE, Murphey ED, Wolfe RR . Lung surfactant kinetics in conscious pigs. Am J Physiol 1999; 277: E187–E195.

    CAS  PubMed  Google Scholar 

  18. Jacobs HC, Ikegami M, Jobe AH, Berry DD, Jones S . Reutilization of surfactant phosphatidylcholine in adult rabbits. Bioch Biophys Acta 1985; 837: 77–84.

    Article  CAS  Google Scholar 

  19. Jobe A, Ikegami M, Sarton-Miller I, Barajas L . Surfactant metabolism of newborn lamb lungs in vivo. J Appl Physiol 1980; 49: 1091–1098.

    Article  CAS  PubMed  Google Scholar 

  20. Jobe A . Metabolism of endogenous surfactant and exogenous surfactant for replacement therapy. Semin Perinatol 1988; 12: 231–239.

    CAS  PubMed  Google Scholar 

  21. Jobe A, Ikegami M, Glatz T, Yoshida Y, Diakomanolis E, Padbury J . Saturated phosphatidylcholine secretion and the effect of natural surfactant on premature and term lambs ventilated for 2 days. Exp Lung Res 1983; 4 (4): 259–267.

    Article  CAS  PubMed  Google Scholar 

  22. Bunt JE, Zimmermann LJ, Wattimena JL, van Beek RH, Sauer PJ, Carnielli VP . Endogenous surfactant turnover in preterm infants measured with stable isotopes. Am J Respir Crit Care Med 1998; 157 (3 Part 1): 810–814.

    Article  CAS  PubMed  Google Scholar 

  23. Merchak A, Janssen DJ, Bohlin K, Patterson BW, Zimmermann LJ, Carnielli VP et al. Endogenous pulmonary surfactant metabolism is not affected by mode of ventilation in premature infants with respiratory distress syndrome. J Pediatr 2002; 140 (6): 693–698.

    Article  CAS  PubMed  Google Scholar 

  24. Cavicchioli P, Zimmermann LJ, Cogo PE, Badon T, Giordano G, Torresin M et al. Endogenous surfactant turnover in preterm infants with respiratory distress syndrome studied with stable isotope lipids. Am J Respir Crit Care Med 2001; 163 (1): 55–60.

    Article  CAS  PubMed  Google Scholar 

  25. Bohlin K, Merchak A, Spence K, Patterson BW, Hamvas A . Endogenous surfactant metabolism in newborn infants with and without respiratory failure. Pediatr Res 2003; 54 (2): 185–191.

    Article  CAS  PubMed  Google Scholar 

  26. Cogo PE, Zimmermann LJ, Rosso F, Tormena F, Gamba P, Verlato G et al. Surfactant synthesis and kinetics in infants with congenital diaphragmatic hernia. Am J Respir Crit Care Med 2002; 166 (2): 154–158.

    Article  PubMed  Google Scholar 

  27. Janssen DJMT . Surfactant phosphatidylcholine metabolism in severe neonatal lung disease studied with stable isotopes. PhD thesis, Erasmus, MC: Rotterdam, The Netherlands, 2003.

  28. Glatz T, Ikegami M, Jobe A . Metabolism of exogenously administered natural surfactant in the newborn lamb. Pediatr Res 1982; 16: 711–715.

    Article  CAS  PubMed  Google Scholar 

  29. Seidner SR, Jobe AH, Coalson JJ, Ikegami M . Abnormal surfactant metabolism and function in preterm ventilated baboons. Am J Respir Crit Care Med 1998; 158 (6): 1982–1989.

    Article  CAS  PubMed  Google Scholar 

  30. Bunt JE, Carnielli VP, Janssen DJ, Wattimena JL, Hop WC, Sauer PJ et al. Treatment with exogenous surfactant stimulates endogenous surfactant synthesis in premature infants with respiratory distress syndrome. Crit Care Med 2000; 28 (10): 3383–3388.

    Article  CAS  PubMed  Google Scholar 

  31. Cogo PE, Carnielli VP, Bunt JE, Badon T, Giordano G, Zacchello F et al. Endogenous surfactant metabolism in critically ill infants measured with stable isotopes labeled fatty acids. Pediatr Res 1999; 45 (2): 242–246.

    Article  CAS  PubMed  Google Scholar 

  32. Oulton M, Fraser M, Dolphin M, Yoon R, Faulkner G . Quantification of surfactant pool sizes in rabbit lung during perinatal development. J Lipid Res 1986; 27 (6): 602–612.

    CAS  PubMed  Google Scholar 

  33. Gluck L, Kulovich MV, Borer Jr RC, Keidel WN . The interpretation and significance of the lecithin–sphingomyelin ratio in amniotic fluid. Am J Obstet Gynecol 1974; 120 (1): 142–155.

    Article  CAS  PubMed  Google Scholar 

  34. Faridy EE, Thliveris JA . Rate of secretion of lung surfactant before and after birth. Respir Physiol 1987; 68 (3): 269–277.

    Article  CAS  PubMed  Google Scholar 

  35. Hallman M, Merritt TA, Pohjavuori M, Gluck L . Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr Res 1986; 20 (12): 1228–1235.

    Article  CAS  PubMed  Google Scholar 

  36. Griese M, Dietrich P, Reinhardt D . Pharmacokinetics of bovine surfactant in neonatal respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152 (3): 1050–1054.

    Article  CAS  PubMed  Google Scholar 

  37. Torresin M, Zimmermann LJ, Cogo PE, Cavicchioli P, Badon T, Giordano G et al. Exogenous surfactant kinetics in infant respiratory distress syndrome: a novel method with stable isotopes. Am J Respir Crit Care Med 2000; 161 (5): 1584–1589.

    Article  CAS  PubMed  Google Scholar 

  38. Cogo PE, Zimmermann LJ, Meneghini L, Mainini N, Bordignon L, Suma V et al. Pulmonary surfactant disaturated-phosphatidylcholine (DSPC) turnover and pool size in newborn infants with congenital diaphragmatic hernia (CDH). Pediatr Res 2003; 54 (5): 653–658.

    Article  CAS  PubMed  Google Scholar 

  39. Oetomo SB, Lewis J, Ikegami M, Jobe AH . Surfactant treatments alter endogenous surfactant metabolism in rabbit lungs. J Appl Physiol 1990; 68 (4): 1590–1596.

    Article  CAS  PubMed  Google Scholar 

  40. Ikegami M, Jobe A, Yamada T, Priestly A, Ruffini L, Rider E et al. Surfactant metabolism in surfactant-treated preterm ventilated lambs. J Appl Physiol 1989; 67 (1): 429–437.

    Article  CAS  PubMed  Google Scholar 

  41. Oguchi K, Ikegami M, Jacobs H, Jobe A . Clearance of large amounts of natural surfactants and liposomes of dipalmitoylphosphatidylcholine from the lungs of rabbits. Exp Lung Res 1985; 9 (3–4): 221–235.

    Article  CAS  PubMed  Google Scholar 

  42. Spragg R, Li J . Effect of phosphocholine cytidylyltransferase overexpression on phosphatidylcholine synthesis in alveolar type II cells and related cell lines. Am J Respir Cell Mol Biol 2000; 22 (1): 116–124.

    Article  CAS  PubMed  Google Scholar 

  43. Rooney SA, Gobran LI, Marino PA, Maniscalco WM, Gross I . Effects of betamethasone on phospholipid content, composition and biosynthesis in the fetal rabbit lung. Biochim Biophys Acta 1979; 572 (1): 64–76.

    Article  CAS  PubMed  Google Scholar 

  44. Ballard PL . Hormonal regulation of pulmonary surfactant. Endocr Rev 1989; 10 (2): 165–181.

    Article  CAS  PubMed  Google Scholar 

  45. Pope TS, Rooney S . A effects of glucocorticoid and thyroid hormones on regulatory enzymes of fatty acid synthesis and glycogen metabolism in developing fetal rat lung. Biochim Biophys Acta 1987; 918 (2): 141–148.

    Article  CAS  PubMed  Google Scholar 

  46. Post M, Barsoumian A, Smith B . The cellular mechanism of glucocorticoid acceleration of fetal lung maturation. Fibroblast-pneumonocyte factor stimulates choline-phosphate cytidylyltransferase activity. J Biol Chem 1986; 261 (5): 2179–2184.

    CAS  PubMed  Google Scholar 

  47. Gonzales LW, Ertsey R, Ballard PL, Froh D, Goerke J, Gonzales J . Glucocorticoid stimulation of fatty acid synthesis in explants of human fetal lung. Biochem Biophys Acta 1990; 1042: 1–12.

    Article  CAS  PubMed  Google Scholar 

  48. Tan RC, Ikegami M, Jobe AH, Yao LY, Possmayer F, Ballard PL . Developmental and glucocorticoid regulation of surfactant protein mRNAs in preterm lambs. Am J Physiol 1999; 277 (6 Part 1): L1142–L1148.

    CAS  PubMed  Google Scholar 

  49. Kessler DL, Truog WE, Murphy JH, Palmer S, Standaert TA, Woodrum DE et al. Experimental hyaline membrane disease in the premature monkey: effects of antenatal dexamethasone. Am Rev Respir Dis 1982; 126 (1): 62–69.

    CAS  PubMed  Google Scholar 

  50. Bunt JE, Carnielli VP, Seidner SR, Ikegami M, Darcos Wattimena JL, Sauer PJ et al. Metabolism of endogenous surfactant in premature baboons and effect of prenatal corticosteroids. Am J Respir Crit Care Med 1999; 160 (5): 1481–1485.

    Article  CAS  PubMed  Google Scholar 

  51. Bunt JE, Carnielli VP, Darcos Wattimena JL, Hop WC, Sauer PJ, Zimmermann LJ . The effect in premature infants of prenatal corticosteroids on endogenous surfactant synthesis as measured with stable isotopes. Am J Respir Crit Care Med 2000; 162 (3 Part 1): 844–849.

    Article  CAS  PubMed  Google Scholar 

  52. Ikegami M, Polk D, Jobe A . Minimum interval from fetal betamethasone treatment to postnatal lung responses in preterm lambs. Am J Obstet Gynecol 1996; 174 (5): 1408–1413.

    Article  CAS  PubMed  Google Scholar 

  53. Beck JC, Mitzner W, Johnson JW, Hutchins GM, Foidart JM, London WT et al. Betamethasone and the rhesus fetus: effect on lung morphometry and connective tissue. Pediatr Res 1981; 15 (3): 235–240.

    Article  CAS  PubMed  Google Scholar 

  54. Walther FJ, Jobe AH, Ikegami M . Repetitive prenatal glucocorticoid therapy reduces oxidative stress in the lungs of preterm lambs. J Appl Physiol 1998; 85 (1): 273–278.

    Article  CAS  PubMed  Google Scholar 

  55. Walther FJ, Ikegami M, Warburton D, Polk DH . Corticosteroids, thyrotropin-releasing hormone, and antioxidant enzymes in preterm lamb lungs. Pediatr Res 1991; 30 (6): 518–521.

    Article  CAS  PubMed  Google Scholar 

  56. Ikegami M, Berry D, elKady T, Pettenazzo A, Seidner S, Jobe A . Corticosteroids and surfactant change lung function and protein leaks in the lungs of ventilated premature rabbits. J Clin Invest 1987; 79: 1371–1378.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Ballard RA, Ballard PL . Antenatal hormone therapy for improving the outcome of the preterm infant. J Perinatol 1996; 16 (5): 390–396.

    CAS  PubMed  Google Scholar 

  58. Pinkerton KE, Willet KE, Peake JL, Sly PD, Jobe AH, Ikegami M . Prenatal glucocorticoid and T4 effects on lung morphology in preterm lambs. Am J Respir Crit Care Med 1997; 156 (2 Part 1): 624–630.

    Article  CAS  PubMed  Google Scholar 

  59. Verlato G, Cogo PE, Balzani M, Gucciardi A, Burattini I, De Benedictis F et al. Surfactant status in preterm neonates recovering from respiratory distress syndrome. Pediatrics 2008; 122 (1): 102–108.

    Article  PubMed  Google Scholar 

  60. Merrill JD, Ballard PL, Hibbs AM, Godinez RI, Godinez MH, Luan X et al. Booster Surfactant Therapy Beyond the First Week of Life in Ventilated Extremely Low Gestational Age Infants. E-PAS2006:59:2635.1, 2006. Available at http://www.abstracts2view.com/pasall/index.php. Accessed on 14 May 2008. 2008.

  61. Herting E, Gefeller O, Land M, van Sonderen L, Harms K, Robertson B . Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Members of the Collaborative European Multicenter Study Group. Pediatrics 2000; 106 (5): 957–964; discussion 1135.

    Article  CAS  PubMed  Google Scholar 

  62. Herting E, Möller O, Schiffmann JH, Robertson B . Surfactant improves oxygenation in infants and children with pneumonia and acute respiratory distress syndrome. Acta Paediatr 2002; 91 (11): 1174–1178.

    Article  CAS  PubMed  Google Scholar 

  63. Finer NN . Surfactant use for neonatal lung injury: beyond respiratory distress syndrome. Paediatr Respir Rev 2004; 5 (Suppl A): S289–S297.

    Article  PubMed  Google Scholar 

  64. Fetter WP, Baerts W, Bos AP, van Lingen RA . Surfactant replacement therapy in neonates with respiratory failure due to bacterial sepsis. Acta Paediatr 1995; 84 (1): 14–16.

    Article  CAS  PubMed  Google Scholar 

  65. Rivera S, Gaugler C, Langlet C, Villega F, Astruc D, Escande B et al. Secondary surfactant deficiencies in extremely low birth weight premature infants. Arch Pediatr 2004; 11 (11): 1346–1350.

    Article  CAS  PubMed  Google Scholar 

  66. Escande B, Kuhn P, Rivera S, Messer J . Secondary surfactant deficiencies. Arch Pediatr 2004; 11 (11): 1351–1359.

    Article  CAS  PubMed  Google Scholar 

  67. Auten RL, Notter RH, Kendig JW, Davis JM, Shapiro DL . Surfactant treatment of full-term newborns with respiratory failure. Pediatrics 1991; 87 (1): 101–107.

    CAS  PubMed  Google Scholar 

  68. Chinese Collaborative Study Group for neonatal respiratory Distress. Treatment of severe meconium aspiration syndrome with porcine surfactant: a multicentre, randomized, controlled trial. Acta Paediatr 2005; 94 (7): 896–902.

    Article  Google Scholar 

  69. Hintz SR, Suttner DM, Sheehan AM, Rhine WD, Van Meurs KP . Decreased use of neonatal extracorporeal membrane oxygenation (ECMO): how new treatment modalities have affected ECMO utilization. Pediatrics 2000; 106 (6): 1339–1343.

    Article  CAS  PubMed  Google Scholar 

  70. Verlato G, Cogo PE, Pesavento R, Gomirato S, Benetazzo A, Gucciardi A et al. Surfactant kinetics in newborn infants with pneumonia and respiratory distress syndrome. Ital J Pediatr 2003; 29: 354–357.

    Google Scholar 

  71. Moses D, Holm BA, Spitale P, Liu MY, Enhorning G . Inhibition of pulmonary surfactant function by meconium. Am J Obstet Gynecol 1991; 164 (2): 477–481.

    Article  CAS  PubMed  Google Scholar 

  72. Sun B, Curstedt T, Robertson B . Surfactant inhibition in experimental meconium aspiration. Acta Paediatr 1993; 82 (2): 182–189.

    Article  CAS  PubMed  Google Scholar 

  73. Bae CW, Takahashi A, Chida S, Sasaki M . Morphology and function of pulmonary surfactant inhibited by meconium. Pediatr Res 1998; 44 (2): 187–191.

    Article  CAS  PubMed  Google Scholar 

  74. Cleary GM, Antunes MJ, Ciesielka DA, Higgins ST, Spitzer AR, Chander A . Exudative lung injury is associated with decreased levels of surfactant proteins in a rat model of meconium aspiration. Pediatrics 1997; 100 (6): 998–1003.

    Article  CAS  PubMed  Google Scholar 

  75. Dargaville PA, South M, McDougall PN . Surfactant and surfactant inhibitors in meconium aspiration syndrome. J Pediatr 2001; 138 (1): 113–115.

    Article  CAS  PubMed  Google Scholar 

  76. Lotze A, Whitsett JA, Kammerman LA, Ritter M, Taylor GA, Short BL . Surfactant protein A concentrations in tracheal aspirate fluid from infants requiring extracorporeal membrane oxygenation. J Pediatr 1990; 116 (3): 435–440.

    Article  CAS  PubMed  Google Scholar 

  77. Lotze A, Knight GR, Martin GR, Bulas DI, Hull WM, O’Donnell RM et al. Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr 1993; 122 (2): 261–268.

    Article  CAS  PubMed  Google Scholar 

  78. Higgins ST, Wu AM, Sen N, Spitzer AR, Chander A . Meconium increases surfactant secretion in isolated rat alveolar type II cells. Pediatr Res 1996; 39 (3): 443–447.

    Article  CAS  PubMed  Google Scholar 

  79. Janssen DJ, Tibboel D, Carnielli VP, van Emmen E, Luijendijk IH, Darcos Wattimena JL et al. Surfactant phosphatidylcholine pool size in human neonates with congenital diaphragmatic hernia requiring ECMO. J Pediatr 2003; 142 (3): 247–252.

    Article  CAS  PubMed  Google Scholar 

  80. Sun B, Cursted T, Robertson B . Exogenous surfactant improves ventilation efficiency and alveolar expansion in rats with meconium aspiration. Am J Respir Crit Care Med 1996; 154 (3 Part 1): 764–770.

    Article  CAS  PubMed  Google Scholar 

  81. Halliday HL, Speer CP, Robertson B . Treatment of severe meconium aspiration syndrome with porcine surfactant. Collaborative Surfactant Study Group. Eur J Pediatr 1996; 155 (12): 1047–1051.

    Article  CAS  PubMed  Google Scholar 

  82. Findlay RD, Taeusch HW, Walther FJ . Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 1996; 97 (1): 48–52.

    CAS  PubMed  Google Scholar 

  83. Lotze A, Mitchell BR, Bulas DI, Zola EM, Shalwitz RA, Gunkel JH . Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure Survanta in Term Infants Study Group. J Pediatr 1998; 132 (1): 40–47.

    Article  CAS  PubMed  Google Scholar 

  84. Cochrane CG, Revak SD, Merritt TA, Schraufstätter IU, Hoch RC, Henderson C et al. Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome. Pediatr Res 1998; 44 (5): 705–715.

    Article  CAS  PubMed  Google Scholar 

  85. Möller JC, Kohl M, Reiss I, Diederich W, Nitsche EM, Göpel W et al. Saline lavage with substitution of bovine surfactant in term neonates with meconium aspiration syndrome (MAS) transferred for extracorporeal membrane oxygenation (ECMO): a pilot study. Crit Care 1999; 3 (1): 19–22.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Wiswell TE, Knight GR, Finer NN, Donn SM, Desai H, Walsh WF et al. A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics 2002; 109 (6): 1081–1087.

    Article  PubMed  Google Scholar 

  87. Glick PL, Stannard VA, Leach CL, Rossman J, Hosada Y, Morin FC et al. Pathophysiology of congenital diaphragmatic hernia II: the fetal lamb CDH model is surfactant deficient. J Pediatr Surg 1992; 27 (3): 382–387; discussion 387–388.

    Article  CAS  PubMed  Google Scholar 

  88. Wilcox DT, Glick PL, Karamanoukian HL, Azizkhan RG, Holm BA . Pathophysiology of congenital diaphragmatic hernia. XII: amniotic fluid lecithin/sphingomyelin ratio and phosphatidylglycerol concentrations do not predict surfactant status in congenital diaphragmatic hernia. J Pediatr Surg 1995; 30 (3): 410–412.

    Article  CAS  PubMed  Google Scholar 

  89. Sullivan KM, Hawgood S, Flake AW, Harrison MR, Adzick NS . Amniotic fluid phospholipid analysis in the fetus with congenital diaphragmatic hernia. J Pediatr Surg 1994; 29 (8): 1020–1023.

    Article  CAS  PubMed  Google Scholar 

  90. Moya FR, Thomas VL, Romaguera J, Mysore MR, Maberry M, Bernard A et al. Fetal lung maturation in congenital diaphragmatic hernia. Am J Obstet Gynecol 1995; 173 (5): 1401–1405.

    Article  CAS  PubMed  Google Scholar 

  91. Minowa H, Takahashi Y, Kawaguchi C, Sadou T, Konishi N, Nishikubo T et al. Expression of intrapulmonary surfactant apoprotein-A in autopsied lungs: comparative study of cases with or without pulmonary hypoplasia. Pediatr Res 2000; 48 (5): 674–678.

    Article  CAS  PubMed  Google Scholar 

  92. IJsselstijn H, Zimmermann LJ, Bunt JE, de Jongste JC, Tibboel D . Prospective evaluation of surfactant composition in bronchoalveolar lavage fluid of infants with congenital diaphragmatic hernia and of age-matched controls. Crit Care Med 1998; 26 (3): 573–580.

    Article  CAS  PubMed  Google Scholar 

  93. Cogo PE, Zimmermann LJ, Verlato G, Midrio P, Gucciardi A, Ori C et al. A dual stable isotope tracer method for the measurement of surfactant disaturated-phosphatidylcholine net synthesis in infants with congenital diaphragmatic hernia. Pediatr Res 2004; 56 (2): 184–190.

    Article  CAS  PubMed  Google Scholar 

  94. Bos AP, Tibboel D, Hazebroek FW, Molenaar JC, Lachmann B, Gommers D . Surfactant replacement therapy in high-risk congenital diaphragmatic hernia [letter]. Lancet 1991; 338 (8777): 1279.

    Article  CAS  PubMed  Google Scholar 

  95. Glick PL, Leach CL, Besner GE, Egan EA, Morin FC, Malanowska-Kantoch A et al. Pathophysiology of congenital diaphragmatic hernia. III: exogenous surfactant therapy for the high-risk neonate with CDH. J Pediatr Surg 1992; 27 (7): 866–869.

    Article  CAS  PubMed  Google Scholar 

  96. Lotze A, Knight GR, Anderson KD, Hull WM, Whitsett JA, O’Donnell RM et al. Surfactant (beractant) therapy for infants with congenital diaphragmatic hernia on ECMO: evidence of persistent surfactant deficiency. J Pediatr Surg 1994; 29 (3): 407–412.

    Article  CAS  PubMed  Google Scholar 

  97. Van Meurs K . Is surfactant therapy beneficial in the treatment of the term newborn infant with congenital diaphragmatic hernia? J Pediatr 2004; 145 (3): 312–316.

    Article  CAS  PubMed  Google Scholar 

  98. Lally KP, Lally PA, Langham MR, Hirschl R, Moya FR, Tibboel D et al. Surfactant does not improve survival rate in preterm infants with congenital diaphragmatic hernia. J Pediatr Surg 2004; 39 (6): 829–833.

    Article  PubMed  Google Scholar 

  99. Sakurai Y, Azarow K, Cutz E, Messineo A, Pearl R, Bohn D . Pulmonary barotrauma in congenital diaphragmatic hernia: a clinicopathological correlation. J Pediatr Surg 1999; 34 (12): 1813–1817.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neonatology, Department of Clinical Sciences, Salesi Hospital, Polytechnic University of Marche, Ancona, Italy

    V P Carnielli

  2. Division of Neonatology, Department of Paediatrics, University Hospital Maastricht, Maastricht, The Netherlands

    L J I Zimmermann

  3. Division of Newborn Medicine, Department of Paediatrics, Edward Mallinckrodt Washington University School of Medicine and St Louis Children's Hospital, St Louis, MO, USA

    A Hamvas

  4. Department of Paediatrics, University of Padova, Padova, Italy

    P E Cogo

Authors
  1. V P Carnielli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L J I Zimmermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Hamvas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P E Cogo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V P Carnielli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carnielli, V., Zimmermann, L., Hamvas, A. et al. Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes. J Perinatol 29 (Suppl 2), S29–S37 (2009). https://doi.org/10.1038/jp.2009.32

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2009.32

Keywords

This article is cited by

Search

Advanced search

Quick links